EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Interobserver Reliability of the 5-Point Deauville Score and SUV-Based Quantification of FDG PET/CT Scans in High-Risk Pediatric Hodgkin Lymphoma

Inki Lee, Sarah A. Milgrom, Hyung-Jun Im, Qinglin Pei, Lindsay Renfro, Bradford S. Hoppe, Kathleen M. McCarten, Cindy L. Schwartz, Peter D. Cole, Kara M. Kelly, Steve Y. Cho

Clinical Nuclear Medicine Open · 2024

DOI: 10.1097/nm9.0000000000000011 ↗
AbstractBibliografische Angaben

Abstract

Purpose In lymphomas, the Deauville score (DS) standardizes 18 F-FDG PET treatment response assessments. We assessed interobserver agreement of the DS and developed a quantitative PET-based parameter to minimize subjectivity of response assessments. Methods PET scans performed within the Children’s Oncology Group AHOD0831 study were analyzed. One hundred one scans obtained after the first cycle of chemotherapy (PET1) and 83 obtained after the second cycle (PET2) were eligible for inclusion. Each scan was assigned a DS by 2 nuclear medicine radiologists and a Hodgkin lymphoma index (HLI), defined as the ratio of the tumor’s SUV max or SUV peak to the liver’s SUV mean . Cohen κ coefficient measured the rate of agreement of the DS assigned by the 2 radiologists. Receiver operating characteristic curves and the Youden index were used with the consensus DS to identify an optimal HLI cutoff value to distinguish PET-negative from PET-positive images. For each HLI cutoff value, sensitivity, specificity, and accuracy were calculated. Results Interobserver agreement in DS was moderate (PET1: κ = 0.480, P < 0.001; PET2: κ = 0.428, P < 0.001). On PET1, the optimal cutoff values for HLI max were 1.19 for DS2/DS3 and 1.78 for DS3/DS4, and for HLI peak were 1.19 for DS2/DS3 and 1.44 for DS3/DS4. On PET2 images, the corresponding values were 1.18, 1.58, 0.94, and 1.26. The most accurate predictor was HLI max on PET2 when scans were dichotomized as DS1–DS3 versus DS4–DS5 (accuracy, 92.8%; sensitivity, 100%; specificity, 91.8%). Conclusion The HLI provides an objective, quantitative measure of disease response and thus may improve interreader agreement for lymphoma response assessments.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →